These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 347804)

  • 21. [Daily profile of pulse rate and blood pressure. Use of betablocker-diuretic combination (author's transl)].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1981 Jan; 123(4):124-8. PubMed ID: 6783878
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination].
    Teufel W; Glocke M
    Med Klin; 1981 Aug; 76(18):513-5. PubMed ID: 6116170
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study (author's transl)].
    Hoffmann J; Schrey A; Grund R; Forst T
    MMW Munch Med Wochenschr; 1981 Mar; 123(12):483-8. PubMed ID: 6783861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Double-blind study of the treatment of essential arterial hypertension with timolol and hydrochlorothiazide separately or in combination].
    Moscovici H; Occhialini RP; Glitz T; Pinheiro JP; Shiguematsu S; Lion MF
    Arq Bras Cardiol; 1977 Jun; 30(3):187-91. PubMed ID: 336012
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of propranolol and atenolol in hypertension.
    Zacharias FJ; Cowen KJ
    Postgrad Med J; 1977; 53 Suppl 3():111-3. PubMed ID: 337264
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal physiology and the treatment of hypertension.
    Cade R; Juncos L; Tarrant D; Mahoney J; Raulerson D
    Compr Ther; 1977 Jan; 3(1):41-7. PubMed ID: 318955
    [No Abstract]   [Full Text] [Related]  

  • 31. [Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
    Mohallen KL; do Patrocínio LL; Célnik D; Kruczan DD; Pinheiro L; Weitzel LH; Bosco J; Sekeff JA; Azevedo Ade C
    Arq Bras Cardiol; 1987 Jun; 48(6):345-50. PubMed ID: 2965568
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the hypotensive effect of atenolol].
    Sznajderman M; Brym E; Cybulska I; Czerniewska E; Niegowska J
    Kardiol Pol; 1979; 22(6):661-6. PubMed ID: 393889
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of hydrochlorothiazide and hydrochlorothiazide plus bevantolol in hypertension.
    Lucas CP; Morledge JH; Tessman DK
    Clin Ther; 1985; 8(1):49-60. PubMed ID: 2870810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of atenolol--a Swedish multicentre study.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Postgrad Med J; 1977; 53 Suppl 3():98. PubMed ID: 337274
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies with atenolol in hypertension.
    Petrie JC; Jeffers TA; Galloway DB; Webster J
    Postgrad Med J; 1977; 53 Suppl 3():173-5. PubMed ID: 337272
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atenolol as primary therapy in previously untreated hypertensives and as an adjuvant to other therapy. A South African Multicentre Study.
    Cilliers AJ
    S Afr Med J; 1979 Mar; 55(9):321-4. PubMed ID: 375435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.